395 related articles for article (PubMed ID: 18976801)
21. Predicting the outcome of squamous cell carcinoma of the uterine cervix using combinations of individual tumor marker expressions.
Lindström AK; Stendahl U; Tot T; Lidström BM; Hellberg D
Anticancer Res; 2007; 27(3B):1609-15. PubMed ID: 17595784
[TBL] [Abstract][Full Text] [Related]
22. [Expression of COX-2 and MMP-9 in cervical carcinoma and their clinical significance].
Luo CF; Zhu RQ; Wang H; Lu YL
Zhonghua Zhong Liu Za Zhi; 2007 Jul; 29(7):526-30. PubMed ID: 18069634
[TBL] [Abstract][Full Text] [Related]
23. Vascular endothelial growth factor a and proliferation marker in prediction of lymph node metastasis in oral and pharyngeal squamous cell carcinoma.
Boonkitticharoen V; Kulapaditharom B; Leopairut J; Kraiphibul P; Larbcharoensub N; Cheewaruangroj W; Chintrakarn C; Pochanukul L
Arch Otolaryngol Head Neck Surg; 2008 Dec; 134(12):1305-11. PubMed ID: 19075127
[TBL] [Abstract][Full Text] [Related]
24. Vascular endothelial growth factor (VEGF) expression correlates with p53 and ki-67 expressions in tongue squamous cell carcinoma.
Mineta H; Miura K; Ogino T; Takebayashi S; Misawa K; Ueda Y
Anticancer Res; 2002; 22(2B):1039-44. PubMed ID: 12168898
[TBL] [Abstract][Full Text] [Related]
25. Prognostic impact of HIF-1alpha expression in patients with definitive radiotherapy for cervical cancer.
Dellas K; Bache M; Pigorsch SU; Taubert H; Kappler M; Holzapfel D; Zorn E; Holzhausen HJ; Haensgen G
Strahlenther Onkol; 2008 Mar; 184(3):169-74. PubMed ID: 18330514
[TBL] [Abstract][Full Text] [Related]
26. Ras p21 immunostaining in early stage squamous cervical carcinoma: relationship with lymph nodal involvement and 72 kDa-metalloproteinase index.
Garzetti GG; Ciavattini A; Lucarini G; Goteri G; Nictolis MD; Romanini C; Biagini G
Anticancer Res; 1998; 18(1B):609-13. PubMed ID: 9568185
[TBL] [Abstract][Full Text] [Related]
27. Expression of BDNF, TrkB, and p53 in early-stage squamous cell carcinoma of the uterine cervix.
Moon A; Won KY; Lee JY; Kang I; Lee SK; Lee J
Pathology; 2011 Aug; 43(5):453-8. PubMed ID: 21670725
[TBL] [Abstract][Full Text] [Related]
28. Prognostic significance of vascular endothelial growth factor and cyclooxygenase-2 in patients with rectal cancer treated with preoperative radiotherapy.
Giralt J; Navalpotro B; Hermosilla E; de Torres I; Espin E; Reyes V; Cerezo L; de las Heras M; Ramon y Cajal S; Armengol M; Benavente S
Oncology; 2006; 71(5-6):312-9. PubMed ID: 17687192
[TBL] [Abstract][Full Text] [Related]
29. Immunohistochemical expression of bcl-2 in UICC stage I and III colorectal carcinoma patients: correlation with c-erbB-2, p53, ki-67, CD44, laminin and collagen IV in evaluating prognostic significance.
Zavrides H; Zizi-Sermpetzoglou A; Elemenoglou I; Papatheofanis I; Peros G; Athanasas G; Panousopoulos D
Pol J Pathol; 2006; 57(3):149-59. PubMed ID: 17219742
[TBL] [Abstract][Full Text] [Related]
30. Predictive value of cell cycle biomarkers in nonmuscle invasive bladder transitional cell carcinoma.
Shariat SF; Ashfaq R; Sagalowsky AI; Lotan Y
J Urol; 2007 Feb; 177(2):481-7; discussion 487. PubMed ID: 17222615
[TBL] [Abstract][Full Text] [Related]
31. Comparative analysis of immunohistochemical markers with invasiveness and histologic differentiation in squamous cell carcinoma and basal cell carcinoma of the skin.
Son KD; Kim TJ; Lee YS; Park GS; Han KT; Lim JS; Kang CS
J Surg Oncol; 2008 Jun; 97(7):615-20. PubMed ID: 18404670
[TBL] [Abstract][Full Text] [Related]
32. Prognostic value of EphA2 and EphrinA-1 in squamous cell cervical carcinoma.
Wu D; Suo Z; Kristensen GB; Li S; Troen G; Holm R; Nesland JM
Gynecol Oncol; 2004 Aug; 94(2):312-9. PubMed ID: 15297167
[TBL] [Abstract][Full Text] [Related]
33. Activated VEGFR2/KDR pathway in tumour cells and tumour associated vessels of colorectal cancer.
Giatromanolaki A; Koukourakis MI; Sivridis E; Chlouverakis G; Vourvouhaki E; Turley H; Harris AL; Gatter KC
Eur J Clin Invest; 2007 Nov; 37(11):878-86. PubMed ID: 17883421
[TBL] [Abstract][Full Text] [Related]
34. Prognostic significance of p21 protein expression in patients with pulmonary squamous cell carcinoma following induction chemotherapy.
Tamura M; Sawabata N; Kobayashi S; Umezu H; Seki N; Yoshii N; Karube Y; Araki O; Ishihama H; Nagai S; Miyoshi S
Ann Thorac Cardiovasc Surg; 2007 Feb; 13(1):9-14. PubMed ID: 17392664
[TBL] [Abstract][Full Text] [Related]
35. Inverse prognostic impact of angiogenic marker expression in tumor cells versus stromal cells in non small cell lung cancer.
Donnem T; Al-Saad S; Al-Shibli K; Delghandi MP; Persson M; Nilsen MN; Busund LT; Bremnes RM
Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6649-57. PubMed ID: 18006765
[TBL] [Abstract][Full Text] [Related]
36. Expression of HIPK2 in cervical cancer: correlation with clinicopathology and prognosis.
Al-Beiti MA; Lu X
Aust N Z J Obstet Gynaecol; 2008 Jun; 48(3):329-36. PubMed ID: 18532967
[TBL] [Abstract][Full Text] [Related]
37. [Assessment tumor markers by immunohistochemistry (Ki67, p53 and Bcl-2) on a cohort of patients with cervical cancer in various stages of evolution].
Stoenescu TM; Ivan LD; Stoenescu N; Azoicăi D
Rev Med Chir Soc Med Nat Iasi; 2011; 115(2):485-92. PubMed ID: 21870745
[TBL] [Abstract][Full Text] [Related]
38. Comparative analysis of prognostic significance of molecular markers of apoptosis with clinical stage and tumor differentiation in patients with colorectal cancer: a single institute experience.
Ivanov K; Kolev N; Tonev A; Nikolova G; Krasnaliev I; Softova E; Tonchev A
Hepatogastroenterology; 2009; 56(89):94-8. PubMed ID: 19453036
[TBL] [Abstract][Full Text] [Related]
39. Association of syndecan-1 with tumor grade and histology in primary invasive cervical carcinoma.
Rintala M; Inki P; Klemi P; Jalkanen M; Grénman S
Gynecol Oncol; 1999 Dec; 75(3):372-8. PubMed ID: 10600292
[TBL] [Abstract][Full Text] [Related]
40. [Expression correlation of Ki67 to P53,VEGF,and C-erbB-2 genes in breast cancer and their clinical significances].
Li BJ; Zhu ZH; Wang JY; Hou JH; Zhao JM; Zhang PY; Yao GY; Wang X; Long H; Yang MT; Rong TH
Ai Zheng; 2004 Oct; 23(10):1176-9. PubMed ID: 15473930
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
